Dr. Kim Kuypers and Natasha Mason were invited to speak at and participate in an event in Helsinki, Finland, discussing research on the therapeutic potential and mechanisms of action of psilocybin and MDMA. The panel discussion has now been posted, and can be viewed here.
Tag: psilocybin
A single dose of psilocybin enhances creative thinking and empathy up to seven days after use, study finds
New research from our group provides more evidence that psilocybin, the active ingredient in magic mushrooms, can improve creative thinking, empathy, and subjective well-being. Read more here, here ,and here.
Psychedelics & Cognitive Flexibility: Therapeutic Implications – Natasha Mason
Amsterdam Psychedelic Research Association 02/06/18 In the last decade, there has been a renewed scientific interest in the utility of psychedelics. Increasing evidence suggests that psychedelics like ayahuasca and psilocybin may have potential therapeutic value for disorders like depression, PTSD, and anxiety. The focus of such investigations has been on psychedelics capacity to reduce symptoms… Continue reading Psychedelics & Cognitive Flexibility: Therapeutic Implications – Natasha Mason
The Effects of Psilocybin on Cognitive Flexibility: A Placebo-Controlled Experimental Study – Natasha Mason
Find video here Beyond Psychedelics, Prague, 23-6-2018
